Notice of general meeting in Probi AB (publ)

The shareholders of Probi AB (publ) are hereby officially convened to the Annual
General Meeting (AGM) which will be held on Thursday 23 April 2015 at 3:00 p.m.
at Elite Hotel, Ideon Gateway, Scheelevägen 27, Lund, Sweden. The intention to
participate must have been notified to the company no later than Friday, 17
April 2015 at 4:00 p.m.

Right to participate

To be entitled to participate in the AGM, shareholders must be registered in the
shareholders’ register maintained by Euroclear Sweden AB as of Friday, 17 April
2015 and have notified the company of their intention to participate no later
than Friday, 17 April 2015 at 4:00 p.m.

Shareholders whose shares are registered with a trustee must temporarily re
-register their shares in their own name with Euroclear Sweden AB to be able to
participate in the Meeting. Such registration must be completed no later than
Friday, 17 April 2015. This means that shareholders must notify the trustee of
their intention to temporarily re-register these shares in ample time before
this date.

Notification of participation

Notification of participation in the AGM is to be made by letter to the address
Probi AB (publ), Ideon, Gamma 1, SE-223 70 Lund, Sweden, by e-mail to
probi@probi.se or by telephone to +46-46-286 89 70. The application must include
the shareholder’s name, personal identification number or corporate registration
number and, where applicable, the number of advisors (max. two) intending to
participate in the Meeting. If shareholders intend to be represented by proxy, a
power of attorney and other authorisation documents must be included with the
application. A power of attorney form is available from the company’s website
www.probi.se.

Proposed agenda

 1. Opening of the meeting
 2. Election of Chairman of the Meeting
 3. Preparation and approval of the list of shareholders entitled to vote at the
Meeting
 4. Approval of the agenda
 5. Election of one or two officers to verify the minutes
 6. Determination of whether the Meeting has been duly convened
 7. Presentation of the annual report and the auditors’ report, and the
consolidated financial report and auditors’ report on the consolidated financial
report
 8. Address by the Chief Executive Officer
 9. Motions concerning the adoption of the income statement and balance sheet,
and of the consolidated income statement and consolidated balance sheet
10. Motions concerning the appropriation of the company’s profit or loss as
shown in the balance sheet adopted by the Meeting
11. Motions concerning the discharge of the Board of Directors and the President
from personal liability for their administration
12. Approval of director fees and auditors fees
13. Approval of the number of Board Members and Deputy Board Members and number
of Auditors and Deputy Auditors.
14. Election of members of the Board and Chairman of the Board.
15. Election of auditors.
16. The Board’s motion concerning guidelines for remuneration of senior
executives
17. Appointment of a Nomination Committee
18. Closing of the meeting

Appendix: Notice of general meeting in Probi AB 2015.

The information is such that Probi AB must disclose in accordance with the
Swedish Securities Market Act and/or the Financial Instruments Trading Act.

FOR FURTHER INFORMATION, CONTACT:

Peter Nählstedt, CEO, Probi, tel +46 46 286 89 23 or mobile +46 723 86 99 83, e
-mail: peter.nahlstedt@probi.se

Niklas Brandt, CFO, Probi, tel +46 46 286 89 26 or mobile +46 706 62 98 83, e
-mail: niklas.brandt@probi.se

ABOUT PROBI

Probi AB is a Swedish publicly traded bioengineering company that develops
effective and well-documented probiotics. Through its world-leading research,
Probi has created a strong product portfolio in the gastrointestinal health and
immune system niches. Probi’s products are available to consumers in more than
30 countries worldwide. Probi’s customers are leading food, health-product and
pharmaceutical companies in the Functional Food and Consumer Healthcare
segments. In 2014, Probi had sales of MSEK 135. The Probi share is listed on
NASDAQ OMX Stockholm, Small Cap. Probi has about 3,000 shareholders. Read more
at www.probi.se